Sir Andrew Witty

Chief Executive Officer


Andrew Witty is chief executive officer of Optum, global health services leader and part of UnitedHealth Group. He was named CEO in 2018, after serving as a UnitedHealth Group company director.

Witty served as chief executive officer and a director of leading pharmaceutical manufacturer GlaxoSmithKline (GSK) from 2008 to 2017. He joined GSK in 1985, and prior to being named CEO served as president of GSK Europe. Before that, he held a variety of international leadership roles for GSK in markets including Asia-Pacific.

Witty is former chancellor of the University of Nottingham, a British public research university, and serves on the Singapore Economic Development Board International Advisory Committee. He is an advisor to 8VC and Hatteras Venture Partners, as well as to the Bill and Melinda Gates Foundation, and a Non-Executive Director of G1 Therapeutics.

Witty was knighted in 2012 for services to the U.K. economy. In 2017, he was named an Honorary Citizen by Singapore for his contributions to the country’s growth and development.